Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kyogo Ito"'
Autor:
Kazumasa Oshima, Kyogo Ito, Eriko Konishi, Tsuyoshi Yamamoto, Jun Fukai, Toshihisa Kajiwara, Masahiro Kishida
Publikováno v:
RSC Advances. 12:17655-17660
Rh metal particles supported on TiO2 could reduce Se(vi) to Se(0) in aqueous solution. Although a hydrazine reductant caused deactivation due to covering, a formaldehyde reductant led to a stable reaction due to deposition in isolation.
Autor:
Kyogo Ito, Shigeru Takeda, Hiroaki Nagano, Masao Nakajima, Yutaka Kawakami, Shinobu Tomochika, Ryouichi Tsunedomi, Keiko Udaka, Yoshitaro Shindo, Satoko Matsueda, Shoichi Hazama, Shigefumi Yoshino, Michihisa Iida, Kiyotaka Okuno, Hiroko Takenouchi, Hiroto Matsui, Nobuaki Suzuki, Yukio Tokumitsu, Shinsuke Kanekiyo, Yoshihiro Tokuhisa, Shigeru Yamamoto, Kazuhiko Sakamoto
Publikováno v:
Oncology Reports.
Cancer vaccines have been developed as a new therapeutic approach, however, their clinical benefit remains limited. We previously performed a phase II study for advanced colorectal cancer (CRC) using five human leukocyte antigen (HLA-A*24:02)-restric
Autor:
Kyogo Itoh, Satoko Matsueda
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 803 (2024)
In this comprehensive review, we explore the pivotal role of commensal Bifidobacterium (c-BIF) as potent non-self-antigens through antigenic mimicry, along with exploring the potential of humoral immune responses for both malignant and non-malignant
Externí odkaz:
https://doaj.org/article/e1518d5837c14266ae5e7e40b7fee2d3
Autor:
Ayako Ono, Naofumi Hikita, Kimitaka Sagawa, Manabu Mochizuki, Toshiki Watanabe, Kyogo Ito, Kazunari Yamaguchi, Eiko Ikeda
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13:S50-S56
Human T-cell lymphotropic virus type I (HTLV-I) is known to cause adult T-cell leukemia/T-cell lymphoma and tropical spastic paraparesis/HTLV-I-associated myelopathy. Recent seroepidemiologic, clinical, and virologic studies indicate that the virus i
Autor:
Kyogo Ito
Publikováno v:
Nishi Nihon Hifuka. 56:423-429
ヒトメラノーマは薬剤や放射線抵抗性である一方で免疫療法に感受性があるため多くの免疫療法が実施されてきた。また腫瘍抗原性も高いため腫瘍免疫学領域では膨大な数の研究が報告
Autor:
Kyogo Ito
Publikováno v:
Japanese Journal of Clinical Immunology. 17:77-83
Autor:
Kyogo Ito
Publikováno v:
Japanese Journal of Clinical Immunology. 16:525-529
Autor:
Hisao Endo, Yusuke Harada, Masahiko Fujii, Kyogo Ito, Motoo Saito, Hiroshi Irie, Yoshinobu Shimizu, Yutaka Sugawara, Katsuo Kumagai, Kimura Takao, Eri Kurokawa
Publikováno v:
Microbiology and Immunology. 33:467-477
We have studied the protective effect of OK-432, a biological response modifier (BRM) of Streptococcus pyogenes origin, on the lethal infection of mice with herpes simplex virus (HSV)-1. A single intraperitoneal (i.p.) injection of more than 10 micro
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
High-mobility group box 1 (HMGB1) is a nuclear protein that is known to be secreted into extracellular fluids from injured cells, activated macrophages, and tumor cells. The clinical correlation of circulating HMGB1 levels with various diseases inclu
Externí odkaz:
https://doaj.org/article/a2ee2e5b3ee947799ff5258af036c0ed
Autor:
Koichi Takayama, Shunichi Sugawara, Yasuo Saijo, Makoto Maemondo, Atsushi Sato, Shinzo Takamori, Taishi Harada, Tetsuro Sasada, Tatsuyuki Kakuma, Junji Kishimoto, Akira Yamada, Masanori Noguchi, Kyogo Itoh, Yoichi Nakanishi
Publikováno v:
Journal of Immunology Research, Vol 2016 (2016)
Objectives. To evaluate the efficacy and safety of personalized peptide vaccination (PPV) combined with chemotherapy for patients with previously treated advanced non-small-cell lung cancer (NSCLC). Patients and Methods. Previously treated PS0-1 pati
Externí odkaz:
https://doaj.org/article/63b25f2fda2442d389ea8c13949a9802